// App-Quantinova.ai

P163 : Biosamples from at risk SSc patients show classic pathological signs of scleroderma: opportunity for a diagnosis of pre-clinical SSc

Researchers

Presenter

  • Rebecca L Ross

Principal Investigators

  • Ioanna Georgiou

  • Antonio Carriero

  • Giuseppina Abignano

  • Chris Wasson

  • Gemma Migneco

  • Ariane Herrick

  • Chris Denton

  • Francesco Del Galdo

Medical Centers

  • School of Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UNITED KINGDOM

  • Division of Musculoskeletal & Dermatological Sciences, Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UNITED KINGDOM

  • Rheumatology, Division of Medicine, London, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • Caveolin 1

  • Cluster of Differentiation 31

  • C-X-C motif chemokine ligand 9

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved